ALDURAZYME
ALDURAZYME
Approved
DIN Number
02254506
Drug Class
Human
Market Date
Aug 12, 2004
Company
HC
sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02254506
AIG Number0150149001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
A16AB05 LARONIDASE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification44:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
LARONIDASEActive
Strength: 0.58 MG / ML
Monograph: LARONIDASE